Staar Surgical Co (STAA)
27.30
-1.14
(-4.01%)
USD |
NASDAQ |
Nov 14, 16:00
27.30
0.00 (0.00%)
After-Hours: 17:14
Staar Surgical Revenue (Annual): 322.42M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 322.42M |
December 31, 2022 | 284.39M |
December 31, 2021 | 230.47M |
December 31, 2020 | 163.46M |
December 31, 2019 | 150.18M |
December 31, 2018 | 123.95M |
December 31, 2017 | 90.61M |
December 31, 2016 | 82.43M |
December 31, 2015 | 77.12M |
December 31, 2014 | 77.12M |
December 31, 2013 | 72.22M |
December 31, 2012 | 63.78M |
December 31, 2011 | 62.76M |
December 31, 2010 | 54.96M |
December 31, 2009 | 51.06M |
December 31, 2008 | 74.89M |
December 31, 2007 | 59.36M |
December 31, 2006 | 56.28M |
Date | Value |
---|---|
December 31, 2005 | 51.30M |
December 31, 2004 | 51.68M |
December 31, 2003 | 50.46M |
December 31, 2002 | 48.25M |
December 31, 2001 | 50.24M |
December 31, 2000 | 53.99M |
December 31, 1999 | 59.00M |
December 31, 1998 | 54.20M |
December 31, 1997 | 42.50M |
December 31, 1996 | 42.20M |
December 31, 1995 | 34.70M |
December 31, 1994 | 27.40M |
December 31, 1993 | 20.10M |
December 31, 1992 | 10.20M |
December 31, 1991 | 4.30M |
December 31, 1990 | 4.50M |
December 31, 1989 | 4.50M |
December 31, 1988 | 6.80M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
150.18M
Minimum
2019
322.42M
Maximum
2023
230.18M
Average
230.47M
Median
2021
Revenue (Annual) Benchmarks
The Cooper Companies Inc | 3.593B |
OrthoPediatrics Corp | 148.73M |
NexGel Inc | 4.089M |
Innovative Eyewear Inc | 1.152M |
Perspective Therapeutics Inc | -- |